Annual Interest Expense
$11.33 M
+$59.00 K+0.52%
31 December 2023
Summary:
Travere Therapeutics annual interest expense is currently $11.33 million, with the most recent change of +$59.00 thousand (+0.52%) on 31 December 2023. During the last 3 years, it has fallen by -$7.72 million (-40.50%). TVTX annual interest expense is now -43.73% below its all-time high of $20.14 million, reached on 31 December 2021.TVTX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$2.78 M
-$11.00 K-0.39%
30 September 2024
Summary:
Travere Therapeutics quarterly interest expense is currently $2.78 million, with the most recent change of -$11.00 thousand (-0.39%) on 30 September 2024. Over the past year, it has dropped by -$44.00 thousand (-1.56%). TVTX quarterly interest expense is now -47.81% below its all-time high of $5.32 million, reached on 31 March 2021.TVTX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$11.19 M
-$44.00 K-0.39%
30 September 2024
Summary:
Travere Therapeutics TTM interest expense is currently $11.19 million, with the most recent change of -$44.00 thousand (-0.39%) on 30 September 2024. Over the past year, it has dropped by -$186.00 thousand (-1.64%). TVTX TTM interest expense is now -43.60% below its all-time high of $19.84 million, reached on 30 September 2021.TVTX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TVTX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.5% | -1.6% | -1.6% |
| 3 y3 years | -40.5% | -43.3% | -43.6% |
| 5 y5 years | +15.5% | -38.9% | -41.7% |
TVTX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -43.7% | +0.5% | -43.3% | +10.4% | -43.6% | +0.1% |
| 5 y | 5 years | -43.7% | +15.5% | -47.8% | +10.4% | -43.6% | +0.1% |
| alltime | all time | -43.7% | >+9999.0% | -47.8% | >+9999.0% | -43.6% | >+9999.0% |
Travere Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.78 M(-0.4%) | $11.19 M(-0.4%) |
| June 2024 | - | $2.79 M(-0.4%) | $11.23 M(-0.5%) |
| Mar 2024 | - | $2.80 M(-0.7%) | $11.29 M(-0.4%) |
| Dec 2023 | $11.33 M(+0.5%) | $2.82 M(0.0%) | $11.34 M(-0.3%) |
| Sept 2023 | - | $2.82 M(-0.8%) | $11.37 M(-0.1%) |
| June 2023 | - | $2.84 M(-0.2%) | $11.38 M(-1.1%) |
| Mar 2023 | - | $2.85 M(-0.3%) | $11.51 M(+3.0%) |
| Dec 2022 | $11.28 M(-44.0%) | $2.86 M(+1.0%) | $11.17 M(-13.6%) |
| Sept 2022 | - | $2.83 M(-4.8%) | $12.93 M(-13.8%) |
| June 2022 | - | $2.97 M(+18.2%) | $15.00 M(-11.1%) |
| Mar 2022 | - | $2.52 M(-45.4%) | $16.88 M(-14.3%) |
| Dec 2021 | $20.14 M(+5.7%) | $4.61 M(-5.9%) | $19.68 M(-0.8%) |
| Sept 2021 | - | $4.90 M(+1.0%) | $19.84 M(+0.7%) |
| June 2021 | - | $4.85 M(-8.8%) | $19.70 M(+1.1%) |
| Mar 2021 | - | $5.32 M(+11.7%) | $19.48 M(+2.3%) |
| Dec 2020 | $19.05 M(+1.2%) | $4.76 M(-0.1%) | $19.05 M(+0.9%) |
| Sept 2020 | - | $4.77 M(+2.9%) | $18.89 M(+1.2%) |
| June 2020 | - | $4.63 M(-5.2%) | $18.67 M(-1.0%) |
| Mar 2020 | - | $4.89 M(+6.3%) | $18.85 M(+0.1%) |
| Dec 2019 | $18.83 M(+91.9%) | $4.60 M(+1.1%) | $18.83 M(-1.9%) |
| Sept 2019 | - | $4.55 M(-5.6%) | $19.19 M(+11.7%) |
| June 2019 | - | $4.82 M(-1.0%) | $17.18 M(+28.0%) |
| Mar 2019 | - | $4.87 M(-2.0%) | $13.42 M(+38.2%) |
| Dec 2018 | $9.81 M | $4.96 M(+95.9%) | $9.71 M(+65.9%) |
| Sept 2018 | - | $2.53 M(+139.6%) | $5.85 M(+47.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $1.06 M(-8.5%) | $3.98 M(+11.1%) |
| Mar 2018 | - | $1.16 M(+4.3%) | $3.58 M(+40.0%) |
| Dec 2017 | $4.42 M(-6.6%) | $1.11 M(+67.7%) | $2.56 M(-54.1%) |
| Sept 2017 | - | $660.00 K(+0.3%) | $5.58 M(+6.9%) |
| June 2017 | - | $658.00 K(+398.5%) | $5.21 M(+10.9%) |
| Mar 2017 | - | $132.00 K(-96.8%) | $4.70 M(-0.7%) |
| Dec 2016 | $4.73 M(-38.9%) | $4.13 M(+1279.6%) | $4.73 M(+402.5%) |
| Sept 2016 | - | $299.00 K(+103.4%) | $942.00 K(-29.6%) |
| June 2016 | - | $147.00 K(-9.8%) | $1.34 M(-67.5%) |
| Mar 2016 | - | $163.00 K(-51.1%) | $4.11 M(-46.9%) |
| Dec 2015 | $7.75 M(>+9900.0%) | $333.00 K(-52.1%) | $7.75 M(+4.5%) |
| Sept 2015 | - | $695.00 K(-76.2%) | $7.42 M(-20.7%) |
| June 2015 | - | $2.92 M(-23.1%) | $9.35 M(+8.6%) |
| Mar 2015 | - | $3.80 M(+44.5%) | $8.61 M(+79.0%) |
| Sept 2014 | - | $2.63 M(+20.7%) | $4.81 M(+120.7%) |
| June 2014 | - | $2.18 M(>+9900.0%) | $2.18 M(>+9900.0%) |
| Nov 2012 | - | $500.00(0.0%) | $2000.00(0.0%) |
| Aug 2012 | - | $500.00(0.0%) | $2000.00(0.0%) |
| May 2012 | - | $500.00(0.0%) | $2000.00(0.0%) |
| Feb 2012 | - | $500.00(0.0%) | $2000.00(0.0%) |
| Feb 2012 | $2000.00(-80.6%) | - | - |
| Nov 2011 | - | $500.00(0.0%) | $2000.00(-51.2%) |
| Aug 2011 | - | $500.00(0.0%) | $4100.00(+13.9%) |
| May 2011 | - | $500.00(0.0%) | $3600.00(+16.1%) |
| Feb 2011 | $10.30 K | $500.00(-80.8%) | $3100.00(+19.2%) |
| Nov 2010 | - | $2600.00 | $2600.00 |
FAQ
- What is Travere Therapeutics annual interest expense?
- What is the all time high annual interest expense for Travere Therapeutics?
- What is Travere Therapeutics annual interest expense year-on-year change?
- What is Travere Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Travere Therapeutics?
- What is Travere Therapeutics quarterly interest expense year-on-year change?
- What is Travere Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Travere Therapeutics?
- What is Travere Therapeutics TTM interest expense year-on-year change?
What is Travere Therapeutics annual interest expense?
The current annual interest expense of TVTX is $11.33 M
What is the all time high annual interest expense for Travere Therapeutics?
Travere Therapeutics all-time high annual interest expense is $20.14 M
What is Travere Therapeutics annual interest expense year-on-year change?
Over the past year, TVTX annual interest expense has changed by +$59.00 K (+0.52%)
What is Travere Therapeutics quarterly interest expense?
The current quarterly interest expense of TVTX is $2.78 M
What is the all time high quarterly interest expense for Travere Therapeutics?
Travere Therapeutics all-time high quarterly interest expense is $5.32 M
What is Travere Therapeutics quarterly interest expense year-on-year change?
Over the past year, TVTX quarterly interest expense has changed by -$44.00 K (-1.56%)
What is Travere Therapeutics TTM interest expense?
The current TTM interest expense of TVTX is $11.19 M
What is the all time high TTM interest expense for Travere Therapeutics?
Travere Therapeutics all-time high TTM interest expense is $19.84 M
What is Travere Therapeutics TTM interest expense year-on-year change?
Over the past year, TVTX TTM interest expense has changed by -$186.00 K (-1.64%)